ASCO '23 Entrees
Jun 15, 2023•28 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
We highlight notable data from this month's ASCO annual meeting.
1. SONIA: sequence (1st or 2nd-line) CKD 4/6i in MBC
2. ADAURA OS results and low rate of osimertinib use in control arm
3. Keynote 671: perioperative pembrolizumab in NSCLC
4. PROSPECT: Can radiation therapy be omitted in locally advanced rectal cancer?
5. Nivo-AVD vs. Bv-AVD in stage III Hodgkin's (ages 12+)
6. ZUMA-7: 2nd line Axl-Cel OS benefit in aggressive NHL (early relapse/refractory disease)
7. CARTITUDE-4: Cilta-Cel earlier in MM treatment
For the best experience, listen in Metacast app for iOS or Android